2017
DOI: 10.1053/j.gastro.2017.08.009
|View full text |Cite
|
Sign up to set email alerts
|

The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol

Abstract: In this prospective, randomized, controlled trial, we found that alcohol is not required for effective EUS-guided pancreatic cyst ablation, and when alcohol is removed from the ablation process, there is a significant reduction in associated adverse events. A multi-agent chemotherapeutic ablation admixture did not appear to significantly improve rates of complete ablation compared with the current standard of alcohol lavage followed by paclitaxel alone. ClinicalTrials.gov ID: NCT01475331.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
118
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3
2
2

Relationship

1
6

Authors

Journals

citations
Cited by 85 publications
(118 citation statements)
references
References 25 publications
0
118
0
Order By: Relevance
“…In this randomized double-blind prospective trial, infusion of the chemotherapeutic agent mixed with saline had less adverse reactions compared with alcohol mixed with chemotherapeutic cocktail. 62 At the end of 12 months, the overall complete cyst resolution was 64% (67% in alcohol-free group and 61% in alcohol group), which was not statistically significant between both groups. Pancreatic cyst ablation has been described using the monopolar RFA probe (Habib EUS RFA catheter).…”
Section: Eus-guided Pancreatic Cyst Ablationmentioning
confidence: 78%
“…In this randomized double-blind prospective trial, infusion of the chemotherapeutic agent mixed with saline had less adverse reactions compared with alcohol mixed with chemotherapeutic cocktail. 62 At the end of 12 months, the overall complete cyst resolution was 64% (67% in alcohol-free group and 61% in alcohol group), which was not statistically significant between both groups. Pancreatic cyst ablation has been described using the monopolar RFA probe (Habib EUS RFA catheter).…”
Section: Eus-guided Pancreatic Cyst Ablationmentioning
confidence: 78%
“…Pancreatic cystic lesions (PCLs) are being increasingly recognized on imaging studies, with prevalence increasing with age and ranging from 2 % to 37 % [1]. Mucinous cysts, including mucinous cystic neoplasms (MCNs) and intraductal papillary neoplasms (IPMNs), are the most prevalent type of pancreatic cysts and are at risk of progressing into invasive carcinoma.…”
Section: Introductionmentioning
confidence: 99%
“…These cysts require further management, yet current strategies including radiographic surveillance and surgical resection present their own set of difficulties. Radiographic surveillance is associated with high cost, radiation exposure, and offers no definitive treatment, and surgical resection carries substantial risk for serious adverse events (AEs) (20 %-40 %) and mortality (1 %-3 %) [1]. Endoscopic ultrasound (EUS)-guided fine needle infusion is an evolving and promising method for chemically ablating appropriately selected mucinous type pancreatic cysts with an endoscopic, minimally invasive technique that carries complete ablation rates ranging from 50 % to 79 % [2][3][4].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations